News Medical on MSN19 小时
Dual-target drug may lead to new treatment approach for breast cancer patientsResearchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at ...
University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment.
Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new UVA Cancer Center research ...
University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer ...
16 小时on MSN
A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...
Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...
University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut ...
News Medical on MSN10 小时
MAGE-4 Drives Tumor Growth, Blocks Antitumor ResponseA study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...
UM's faculty boasts leading scholars from diverse cultural backgrounds who are actively engaged in cutting-edge research in ...
1 小时on MSN
Refusing to slow down since the start of the new year, shares of Tempus AI (NASDAQ: TEM) have skyrocketed nearly 99% since ...
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈